Behind the scenes at our #irae “study group” @NohaMDAnderson @LCalabreseDO #ACR20 #Immunotherapy https://t.co/eE7E7Qi1Zq

Dr. Noha Abdel-wahab on timing for grade 3/4 irAE fastest with the skin after exposure to CPI #ACR20 @rheumnow https://t.co/sc5c6Zn3Uq

#hydroxychloroquine is not a ‘cutie’ drug. E Park et al showed that HCQ does not increase QT interval in RA & SLE patients including if on other meds that may affect QT but known heart disease excluded from study #ACR20 #ACR2020 @RheumNow abstr#432 @CRASCRRheum https://t.co/FGVPknmj5q

#ACR20 Break time - go take a hike OR go ride a bike! https://t.co/rYW3p4OgE3

• https://youtu.be/glJUYaAQRv8

@Rhemnow #ACR20 abs0307 analysis of PsA pts diagnostic pathway emphasizes difference in Dx coding by specialty (Derm unlikely to code arthritis, rheum unlikely to code PSO, PCP tend to code general MSK and axial symptoms). PSO and enthesitis codes increased closer to PsA Dx https://t.co/i6ZmjlD3xs

ACHILLES study: Only 56% of pts w/ clinical enthesitis had MRI+ heel enthesitis. MRI screening: HLAB27+ pts likely to be in MRI+ grp. @RheumNow #ACR20 Abstr#0447 #ACRbest https://t.co/m2cjDzYfyg

More UPA safety studies Abst#0215 shows balanced VTE event rates across UPA doses and comparator groups. Evidence for Dr. Strand to use in #ACR20 Great Debate that VTE may be safe TNF alternative @RheumNow. https://t.co/hByttIxiuX

“Immunology is the cornerstone of medicine and we are the experts.” #ACR20 president, Dr. Ellen Gravallese @RheumNow

Sustained DMARD-free remission (SFDR) seen in ACPA- RA pts; DAS levels at 4mos. predictive for SFDR. ACPA+ pts no relation w/ SFDR & DAS course @RheumNow #ACR20 Abstr#479 #ACRbest https://t.co/kko4tO7s1Y

Small study showed poor to fair agreement of PE and US findings of hands in PsA. Do you use US in your clinic for diagnostics? #ABS0314 @RheumNow #ACR20 https://t.co/6oQG4SB1d3 https://t.co/SQK7uhX02T

• Accuracy of Physical Examination to Detect Synovial and Extra-synovial Patholog…

JAKs are no longer new, Winthrop et al presents 8.4 year BARI data in Abst#0202 at #ACR20. VTE risk stable over time, again shows reason to vaccinate patients for zoster before starting. @RheumNow https://t.co/OSIvHl2f7Y

Beautiful poster and fascinating research from @chriswincup et al showing immune cellular iron deficiency in patients with #SLE. Time to add iron supplementation as part of standard #lupus therapy? https://t.co/Uf81KXbSM0 Abs#0294 #ACR20 @RheumNow https://t.co/z5SUjWFkdD

• Tired T-Cells and Monocytes with Malaise: Investigating the Links Between Cellu…

Abst#0181 out of Korea shows MTX use does not increase prevalence of hepatic steatosis. Encouraging data, though retrospective study may underpin provider bias in riskier patients. #ACR20 @RheumNow. https://t.co/HeR5hroYUh

ANA antibodies in longitudinal #SLE cohort: - 759 patients - 84.8% remained ANA+ve during 5yr followup period - Pts w/ at least one -ve ANA in first 5yrs had milder disease (lower SLEDAI-2K, less steroid, fewer autoantibodies) Abs#0251 #ACR20 @RheumNow https://t.co/U7JbNpJA3w

• Dynamics of Anti-Nuclear Antibodies in a Longitudinal Study of a Large Systemic…

Large data from Japanese Ninja database in abst#0183 shows incidence of malignancies in Japanese RA patients similar to Japanese gen pop. Comparable in patients exposed and unexposed to biologics/JAKs. #ACR20 @RheumNow